Latest Insider Transactions at Akoya Biosciences, Inc. (AKYA)
This section provides a real-time view of insider transactions for Akoya Biosciences, Inc. (AKYA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Akoya Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Akoya Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 23
2023
|
Marilee Moy CHIEF PEOPLE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Feb 23
2023
|
Brian Mc Kelligon President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+33.33%
|
-
|
|
Feb 15
2023
|
Niro Ph.D Ramachandran Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34,000
+17.83%
|
$0
$0.91 P/Share
|
|
Dec 22
2022
|
Joseph Driscoll Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+48.78%
|
$0
$0.44 P/Share
|
|
Dec 14
2022
|
Joseph Driscoll Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
24,613
-49.19%
|
$295,356
$12.57 P/Share
|
|
Dec 14
2022
|
Joseph Driscoll Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,613
+32.9%
|
$0
$0.44 P/Share
|
|
Dec 13
2022
|
Thomas P Schnettler Director |
SELL
Open market or private sale
|
Indirect |
71,050
-2.53%
|
$923,650
$13.03 P/Share
|
|
Dec 06
2022
|
Brian Mc Kelligon President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-5.88%
|
$60,000
$12.08 P/Share
|
|
Dec 06
2022
|
Brian Mc Kelligon President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.56%
|
$0
$0.3 P/Share
|
|
Dec 02
2022
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
1,100
-0.19%
|
$14,300
$13.25 P/Share
|
|
Dec 01
2022
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
5,000
-0.84%
|
$65,000
$13.36 P/Share
|
|
Nov 16
2022
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
300
-0.05%
|
$3,900
$13.25 P/Share
|
|
Nov 14
2022
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
600
-0.1%
|
$7,800
$13.28 P/Share
|
|
Nov 11
2022
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
20,000
-3.23%
|
$260,000
$13.29 P/Share
|
|
Nov 10
2022
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
3,810
-0.61%
|
$49,530
$13.31 P/Share
|
|
Sep 14
2022
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
8,305
-1.32%
|
$107,965
$13.26 P/Share
|
|
Sep 12
2022
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
1,800
-0.28%
|
$23,400
$13.3 P/Share
|
|
Sep 09
2022
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
22,191
-3.39%
|
$288,483
$13.31 P/Share
|
|
Sep 07
2022
|
Brian Mc Kelligon President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-5.88%
|
$60,000
$12.83 P/Share
|
|
Sep 07
2022
|
Brian Mc Kelligon President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.56%
|
$0
$0.3 P/Share
|
|
Jun 15
2022
|
Brian Mc Kelligon President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-5.88%
|
$50,000
$10.25 P/Share
|
|
Jun 15
2022
|
Brian Mc Kelligon President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.56%
|
$0
$0.3 P/Share
|
|
Apr 13
2022
|
Niro Ph.D Ramachandran Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,107
+37.97%
|
$0
$0.91 P/Share
|
|
Mar 23
2022
|
Frederic Pla Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+50.0%
|
-
|
|
Mar 23
2022
|
Joseph Driscoll Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
|
Mar 23
2022
|
Niro Ph.D Ramachandran Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+32.11%
|
-
|
|
Mar 23
2022
|
Brian Mc Kelligon President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+50.0%
|
-
|
|
Dec 13
2021
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
100
-0.02%
|
$1,300
$13.25 P/Share
|
|
Dec 09
2021
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
25,000
-3.68%
|
$300,000
$12.67 P/Share
|
|
Nov 22
2021
|
Niro Ph.D Ramachandran Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+49.93%
|
$325,000
$13.13 P/Share
|
|
Nov 19
2021
|
Niro Ph.D Ramachandran Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
73
+50.0%
|
$876
$12.85 P/Share
|
|
Nov 19
2021
|
Scott Mendel Director |
BUY
Open market or private purchase
|
Direct |
8,500
+50.0%
|
$110,500
$13.16 P/Share
|
|
Nov 18
2021
|
Robert G Shepler Director |
BUY
Open market or private purchase
|
Direct |
35,000
+43.18%
|
$420,000
$12.55 P/Share
|